Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles.

Saved in:
Bibliographic Details
Title: Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles.
Authors: Bizzaro CL; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania., Bach CA; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Laboratory of Glycomedicine, Institute of Biology and Experimental Medicine, National Council of Scientific and Technical Investigations, Buenos Aires, Argentina.; Faculty of Exact and Natural Sciences, University of Buenos Aires, Argentina., Santos RA; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania., Verrillo CE; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania., Naranjo NM; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania., Chaudhari I; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania., Picone FJ; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania., Iqbal W; Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania., Blidner AG; Laboratory of Glycomedicine, Institute of Biology and Experimental Medicine, National Council of Scientific and Technical Investigations, Buenos Aires, Argentina., Rabinovich GA; Laboratory of Glycomedicine, Institute of Biology and Experimental Medicine, National Council of Scientific and Technical Investigations, Buenos Aires, Argentina.; Faculty of Exact and Natural Sciences, University of Buenos Aires, Argentina., Fatatis A; Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania.; Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Jacobi J; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Goodrich DW; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Zarrabi KK; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania., Kevin Kelly W; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania., Schiewer MJ; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania., Languino LR; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Source: Molecular cancer research : MCR [Mol Cancer Res] 2025 Jun 03; Vol. 23 (6), pp. 542-552.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3125
DOI:10.1158/1541-7786.MCR-24-0903